New drug BMS-986278 put through safety and heart rhythm tests in healthy people
NCT ID NCT06746402
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 trial tested the safety, tolerability, and heart effects of the drug BMS-986278 in 42 healthy adults. Participants received either the drug, a placebo, or a control medication to check for any impact on heart rhythm. The study aims to ensure the drug is safe before moving to patient trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BMS-986278
- What this could lead to
- If successful, this study could confirm that BMS-986278 is safe enough to test in people with a specific disease.
- What could go wrong
- This is an early, small trial in healthy volunteers, not patients. It only checks safety and heart effects, not whether the drug works for any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ICON San Antonio
San Antonio, Texas, 78209, United States
-
Local Institution - 0001
Salt Lake City, Utah, 84124, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults